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Abstract
Introduction: Previous studies highlight a complex relationship between lineage and phenotype for adipose tissue
macrophages (ATMs), adipose stem cells (ASCs), and adipocytes, suggesting a high degree of plasticity of these cells. In the
present study, using a novel co-culture system, we further characterized the interaction between ATMs, ASCs and
adipocytes.
Research Design and Methods: Human adipocytes and the stromal vascular fraction containing ATMs and ASCs were
isolated from human adipose tissue and co-cultured for 24 hours. FACS was used to characterize ATMs and ASCs before and
after co-culture. Preadipocytes generated after co-culture were characterized by immunostaining for DLK (preadipocytes),
CD14 and CD68 (ATMs), CD34 (ASCs), and Nile Red staining for lipid drops. qRT-PCR was used to quantify adipogenic
markers such as C/EBPa and PPARc. A novel fluorescent nanobead lineage tracing method was utilized before co-culture
where fluorescent nanobeads were internalized by CD68 (+) ATMs.
Results: Co-culture of adipocytes with ATMs and ASCs increased the formation of new preadipocytes, thereby increasing
lipid accumulation and C/EBPa and PPARc gene expression. Preadipocytes originating after co-culture were positive for
markers of preadipocytes, ATMs and ASCs. Moreover, fluorescent nanobeads were internalized by ATMs before co-culture
and the new preadipocytes formed after co-culture also contained fluorescent nanobeads, suggesting that new
preadipocytes originated in part from ATMs. The formation of CD34(+)/CD68(+)/DLK (+) cell spheres supported the
interaction of ATMs, ASCs and preadipocytes.
Conclusions: Cross-talk between adipocytes, ATMs and ASCs promotes preadipocyte formation. The regulation of this novel
adipogenic pathway involves differentiation of ATMs to preadipocytes. The presence of CD34(+)/CD68(+)/DLK(+) cells
grouped in spheres suggest that paracrine interactions between these cell types plays an important role in the generation
and proliferation of new preadipocytes. This phenomenon may reflect the in vivo plasticity of adipose tissue in which ATMs
play an additional role during inflammation and other disease states. Understanding this novel pathway could influence
adipogenesis, leading to new treatments for obesity, inflammation, and type 2 diabetes.
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Introduction
Obesity is a major contributor to chronic disease and disability,
including type 2 diabetes [1]. The role of adipose tissue in obesity
was thought to be a passive one, however, today it is understood
that adipocytes play a much more active role in metabolism,
including interactions with the immune system through inflam-
matory mediators and signaling molecules [2–3]. This inflamma-
tory response appears to be critical in the development of obesity
and later, insulin resistance [4]. In addition, adipose tissue
macrophages (ATMs) and cytokines are able to keep preadipocytes
in quiescent stages, and an imbalance in this mechanism could
exacerbate the development of obesity and insulin resistance
[4–5].
Macrophage expression of adipokine receptors for both leptin
and adiponectin suggests that adipocytes may also modulate
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17834macrophage function [6–7]. In vitro co-culture of differentiated
3T3-L1 adipocytes and RAW 264 macrophages results in
significant upregulation of proinflammatory cytokines and down-
regulation of anti-inflammatory cytokines in the macrophages [8].
Furthermore, the interaction of 3T3-L1 adipocytes with mouse
peritoneal macrophages mediates the production of factors from
macrophages that influence insulin sensitivity in adipocytes [9].
Recent studies demonstrated that co-culture of 3T3-L1 adipocytes
with C2D macrophages inhibits insulin mediated glucose trans-
port, adipocyte differentiation and diminishes macrophage
function [10]. Understanding the range of interactions between
adipocytes and macrophages may elucidate mechanisms underly-
ing the etiology of excess adiposity and obesity.
Adipose tissue is not only composed of adipocytes, macrophages,
and vascular tissue, but it also contains adult adipose stem cells
(ASCs), that can be found in the adipose tissue derived stromal cell
fraction [11–15]. These mesenchymal stem cells first become
preadipocytes, which then can differentiate to adipocytes [11–
14,16–17]. The presence of CD68 (+)/CD34 (+) cellsin adiposetissue
has been recently described in db/db mice. The authors described a
possible role of these cells in adipogenesis and angiogenesis [15].
ASCs can differentiate along adipocyte, osteoblast, chondrocyte,
and other mesenchymal cell lineages in a manner similar to that of
multipotent stromal cells derived from bone marrow [16–18]. It is
generally accepted that mature adipocytes do not regularly
undergo mitosis, and thus, an increase in adipocytes usually
reflects a differentiation of preadipocytes [13–14]. However,
several studies indicate that mature adipocytes could also have
proliferative activity [19–20]. Recent studies suggest adipocytes
can dedifferentiate to preadipocytes [21] and can even differen-
tiate to a multipotent cell population [22,23]. Of note, adipocyte
precursors and preadipocytes have also been recently observed to
rapidly and efficiently differentiate into typical macrophages
[24,25] demonstrating significant plasticity of these cells. Never-
theless, the role of ATMs in adipose tissue biology is still
controversial. In the present study, we demonstrated that co-
culture of adipocytes with ATMs and ASCs results in the robust
proliferation of preadipocytes. In addition, these new preadipo-
cytes can rapidly turn into adipocytes. ATMs can differentiate to
preadipocytes as determined by lineage tracing. This novel
pathway of generation of new preadipocytes/adipocytes also
involved the formation of ATM/ASC/preadipocyte cell spheres.
Thus, this paracrine cross-talk may reflect the in vivo plasticity of
adipose tissue.
Materials and Methods
Subjects
Human adipose tissue samples were obtained from female
patients undergoing abdominoplasty. All patients were premeno-
pausal, non-diabetic, and none had been on any hormonal
treatment, including oral contraceptives. Abdominal adipose tissue
was excised and placed in buffer (12.5 mM Hepes Krebs-Ringer
medium, 4% BSA, 2 mM pyruvate, pH 7.4, at room temperature
(RT). A small amount of tissue was fixed in 4% PBS buffered
paraformaldehyde and subjected to immunofluorescence, and the
remainder was used for adipocyte and macrophage isolation. All
studies were approved by the Cedars-Sinai Medical Center and the
University of California Los Angeles, Institutional Review Board.
Isolation of adipocytes and ATM/ASC fraction from
human adipose tissue
Human adipose tissue was finely minced and treated with
collagenase (Worthington Biochemical Corp., Lakewood, NJ) for
60 minutes at 37uC, in the transport buffer. The cell suspension
was then filtered through a pre-moistened 150-micron nylon mesh
(Small Parts Inc., Miami Lakes, FL) and centrifuged for 2 min at
50 xg at RT. The upper phase (floating adipocytes) was separated
from lower phase. Adipocytes were washed twice and diluted in
adipocyte culture medium (DMEM, 1% BSA, 3% FCS, 100 U/ml
Penicillin, 100 mg/ml Streptomycin). The lower phase was
subjected to centrifugation for 5 minutes at 500 xg. The cell
pellet (ATM/ASC fraction) was resuspended in PBS and a Ficoll
density gradient [26] was used to remove lymphocytes (Lympho-
prep, Greiner Bio-one, Longwood). The interface containing the
ATM/ASC fraction was removed and washed with 5 ml of PBS at
RT. After a final centrifugation for 5 minutes at 500 xg, the cell
pellet was resuspended in regular culture medium (RPMI medium
supplemented with 10% FCS, 100 U/ml penicillin, 100 mg/ml
streptomycin, 2 mM L- glutamine, 1% NEAA, 1% sodium
pyruvate, and 10 ng/ml GM-CSF).
Co-culture of adipocytes and the ATM/ASC fraction
Cells from the ATM/ASC fraction (10
6/ml) and isolated
adipocytes(10
6/ml)wereallowedtoequilibrateseparatelyovernight
in their respective cell culture media. Coverslips were placedin each
well for immunofluorescence studies. Twenty-four hours later,
resuspended adipocytes were added to the wells containing the
macrophage fraction at an approximate 1:1 ratio. The pooled cells
were co-cultured for 24 hours at 37uCi n5 %C O 2. At the end of the
incubation period the adipocytes were resuspended and transferred
by pipette and placed in another well containing 1 ml of adipocyte
culture medium (see above); the remaining ATM/ASC fraction was
washed five times with 1 ml PBS,and cultured for an additional two
or seven days in fresh regular medium (see above) or adipogenic
medium (ZenBio, Research Triangle Park, NC) (Fig. 1A).
Coverslips were then collected for immunofluorescence (see below).
Adipocytes and ATM/ASC fractions were also separately cultured
under the same conditions described above.
Flow cytometry analysis
The ATM/ASC fraction with and without co-culture with
adipocytes was detached from dish using 1 mM EDTA/EGTA in
PBS.After two washes in 2%inactivate FCS/0.05% sodiumAzide/
PBS, cells were resuspended in the same buffer and incubated at
4uC for 1 hour in the presence or absence of primary antibodies
against i) CD14, a macrophage/monocyte specific marker (Bio-
source, Camarillo, CA); ii) CD34, an adult hematopoietic stem cell
marker (Zymed, San Francisco, CA), and iii) DLK, a marker of
preadipocytes and newly formed adipocytes (Santa Cruz, CA). Cells
were then washed two times with same buffer described above and
incubated with the corresponding secondary antibodies for 30
minutes at RT. After two consecutive washes in buffer, cells were
resuspended in100 ml of2%inactivate FCS/0.05%SodiumAzide/
PBS. Analysis of number and type of cells were performed using a
FACS Calibur flow cytometer and cEllQuest Pro software.
Differentiation of preadipocytes to adipocytes
To further characterize the adipogenesis capacity of the new
preadipocytes generated after co-culture, confluent cells from
ATM/ASC fractions with and without co-culture were kept for an
additional seven days in Regular medium (see above) or in
adipogenic medium (see above).
Quantitative Real Time PCR (q-RTPCR)
Total RNA was isolated using RNeasy kits (Qiagen, Hilden,
Germany). First strand cDNA was synthesized using RT2 first
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the manufacturer’s instructions. The primers for C/EBPa and
PPARc for real-time PCR were obtained from Applied Biosystems
(Foster City, CA). qRT-PCR was performed using TaqmanH
Gene Expression kit Applied Biosystems (Foster City, CA). ACTB
and GAPDH were used as internal controls.
Immunofluorescence
Adipocytes were characterized using Dye Nile Red (Sigma-
Aldrich, St. Louis, MO) and DAPI (Vectashield, Vector,
Burlingame, CA) used to according to the manufacturer’s
instructions. Cells present in the ATM/ASC fractions with and
without co-culture were also characterize by immunofluorescence.
Cells on the coverslips were fixed with 4% paraformaldehyde/
PBS, washed with PBS, treated with 0.2% Triton-X-100, and then
blocked with a 4% BSA solution. The samples were incubated
with the primary antibodies overnight at 4uC, washed with PBS
and incubated for one hour with secondary antibodies labeled with
Alexa Fluor 568 and 488 (Invitrogen, Carlsbad, CA). The slides
were then washed with PBS and mounted with mounting medium
containing DAPI (Vectashield, Vector, Burlingame, CA). Whole
tissue mounts were manually cut from excised tissue before being
placed in a well and treated identically to cultured cells. Primary
antibodies used included: i) DLK (see above); ii) CD14 (see above);
iii) CD68, a macrophage, monocyte, and dendritic cell marker
(BD Biosciences, San Diego, CA); iv) CD34, an adult hematopoi-
etic stem cell marker (see above) v) CD105, a mesenchymal stem
cell marker (BD Biosciences, San Diego, CA). In some
experiments preadipocytes were also characterized with S-100
(Sigma Aldrich, St Louis, MO) [27–29].
Labeled nanobead cell lineage analysis
10
7 cells from ATM/ASC fraction were incubated with 10 mlo f
a 1:1 volume slurry of 200–300 nm fluorescent anti-human CD14
nanobeads in PBS (BD Biosciences, San Diego, CA) for 30
minutes at 8uCi n9 0ml PBS, 0.5% BSA, 2 mM EDTA, and
0.09% sodium azide. After incubation, the mixture was layered
over a Ficoll density gradient as described above to separate any
unbound or non-internalized nanobeads from the ATM/ASC
fraction, which was then plated for 24 hours and co-cultured as
described above.
Results
Co-culture of ATMs/ASCs and adipocytes
Isolated adipocytes, prior to co-culture were positive for Nile
Red and DAPI staining and were clearly distinguishable from the
small amount of free lipids (positive Nile Red and negative DAPI
staining) that remained in the adipocyte isolates (Fig. 1B). To
ensure that adipocytes were not contaminated with ATMs we
performed immunostaining in the adipocyte fraction using CD14
antibody, a specific marker for monocytes/macropahges. We were
unable to find adipocytes with CD14 (+) ATM cells (Fig. 1C).
ATMs remained tightly adherent in culture and were negative for
Nile Red indicating that these cells did not have any contamina-
tion of adipocytes (Fig. 1D–E).
Figure 1. Scheme of co-culture between adipocytes, and ATMs/ASCs isolated from adipose tissue. Characterization of the isolated
adipocytes and ATMs present in the ATM/ASC fraction. Isolated adipocytes and ATMs/ASCs were cultured separately for 24 hours to allow the cells to
reach equilibrium and then were co-cultured for an additional 24 hours. Finally, the cells were separated and cultured for another 24 hours or
48 hours. (A) At the end of these periods, the culture media and the cells were subjected to different studies. (B) Nile Red co-labeled with DAPI (light
blue) indicates the presence of mature adipocytes (x100). (C) Immunofluorescence (40X) of adipocytes cultured for 24 hours, cells are CD14 (2). (D)
ATMs/ASCs after 3 days in culture, labeled for CD14 (200X), (E) these cells are Nile Red (-).
doi:10.1371/journal.pone.0017834.g001
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after co-culture
To quantify the number of preadipocytes formed in the ATM/
ASC fraction following co-culture, we performed FACS analysis.
Fig. 2 shows the results of a representative experiment of our
FACS studies. We used DLK as a marker for preadipocytes [30–
31], CD14 for ATMs and CD34 for ASCs. We observed that the
ATM/ASC fraction, which contains ATMs and ASCs and other
cell types, was composed of only 2.4% DLK (+) cells after being
allowed 24 hours of growth prior to co-culture (Fig. 2A). The
same ATM/ASC fraction maintained for 72 hours of growth
without co-culture contained 11.3% of DLK (+) cells, (Fig. 2B). In
contrast, the ATM/ASC fraction that was co-cultured with
adipocytes exhibited a significant increase to 29% of DLK (+)
cells (Fig. 2C). Results of three different experiments indicate a
3–4 fold increase in DLK (+) preadipocytes in the ATM/ASC
fraction after co-culture with adipocytes (p,0.01) (data not
shown). Furthermore, adipocytes that were replated after co-
culturing and cultured for additional 24 hours demonstrated only
minimal additional preadipocyte formation (data not shown). Our
results also suggest that preadipocytes could be derived from
different population of CD34 (+) and CD14 (+) cells (Fig. 2C).
Effect of co-culture in the differentiation of ATM/ASCs to
preadipocytes/adipocytes
In order to further characterize the preadipocytes formed in the
ATM/ASC fraction following co-culture, confluent ATM/ASC
fraction without and with co-culture were kept in regular medium
(see above) for an additional 7 days. In contrast to the untreated
ATM/ASC fraction, preadipocytes derived after co-culture
showed many inclusions with lipid droplets (Nile red (+)/DAPI)
(Fig. 3A vs 3B). In addition, there were significant increases in
C/EBPa (1.6 fold, p,0.01) and PPARc (1.4 fold, p,0.05) gene
expression (Fig. 3C). To further study the effect of co-culture in
adipogenesis, preadipocytes derived after co-culture were kept in
adipogenic medium for additional 7 days. Under these conditions,
the new preadipocytes contained large lipid drops (Fig. 3D vs
3E). In addition, there were significant increases in C/EBPa (3.2
fold, p,0.01) and PPARc (2.6 fold, p,0.001) gene expression
(Fig. 3F). These results indicate that co-culture exacerbate
adipogenesis at an early stage of differentiation (conversion of
ASCs to preadipocytes) as well as during differentiation of
preadipocytes to adipocytes.
Differentiation of ATMs to Preadipocytes
Preadipocyte formation during co-culture of the ATM/ASC
fractions could be attributed to differentiation of CD34 (+) ASCs
[12,14,32] and other cell components present in the ATM/ASC
fraction such as CD68 (+) ATMs. To demonstrate that ATMs could
be a source of preadipocytes, we traced ATMs with fluorescent anti-
human CD14 nanobeads. We induced ATMs to internalize
fluorescence nanobeads prior to co-culture (Fig. 4A, C, D, E).
Indeed, a subset of CD68 (+) ATMs present in the ATM/ASC
fraction was induced to phagocytize the nanobeads. Approximately
90% of these CD68 (+) ATMs phagocytized the nanobeads prior to
co-culture (Fig. 4A, C, D, E). After co-culture of the immuno-
fluorescent labeled ATMs/ASCs with adipocytes, a significant
number of newly formed preadipocytes contained internalized
fluorescent nanobeads suggesting that they were derived from
ATMs (Fig. 4F, H). These nanobead-labeled preadipocytes were
also positive for DLK (+) (Fig. 4G, H), further supporting that the
Figure 2. FACS analysis of the ATM/ASC fraction alone and after co-culture with adipocytes. A monoclonal antibody to DLK was used to
determine the presence of specific subsets of preadipocytes. (A) Before co-culture (total 24 h), (B) without co-culture (total 72 h), (C) with 24 h co-
culture (total 72 h). IgG2a was used as a negative control.
doi:10.1371/journal.pone.0017834.g002
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phagocytic cells from CD 68(+) ATMs. There were also examples of
DAPI (+)/DLK(-) cells that did not internalize any nanobeads
demonstrating the specificity of this assay (Fig. 4H).
Formation of cell spheres after co-culture
We further characterized the origins of the human preadipo-
cytes formed in the ATM/ASC fraction following co-culture with
adipocytes. Unexpectedly, spheres containing CD68 (+)/DLK (+)
and CD34 (+)/S100 (+) cells were detected after 24 hours of co-
culture, indicating an interaction between preadipocytes and
ATMs/ASCs (Fig. 5A, B). Spheres containing CD34 (+)/S100
(+) cells were also CD34 (+)/DLK (+) cells (Data not shown). From
the spheres emerged DLK (+) preadipocytes that also were positive
for CD68 (Fig. 5C) and DLK (+) preadipocytes that were positive
for CD105 (Fig. 5D). The finding that the new preadipocytes
generated in the ATM/ASC fraction were positive for both DLK
and CD105 (classical marker for mesenchymal stem cells) suggests
that they originate from mesenchymal stem cell differentiation
pathways [11,12,14,32]. These results suggest that co-culture
between adipocytes with ATMs/ASCs may generate of CD68 (+)/
CD34 (+)/preadipocyte cell spheres in an ancillary mechanism to
the proliferation of new preadipocytes in humans.
Discussion
Our results demonstrate that cross-talk between ATMs, ASCs
and adipocytes induce the formation of new preadipocytes that
can rapidly differentiate into adipocytes. This novel pathway of
adipogenesis involves differentiation of ATM to preadipocytes as
well as the formation of CD14(+)/CD34(+)/preadipocyte cell
spheres from which many preadipocytes are released.
Adipose tissue is a complex population of cells that modulate
not only adipose tissue biology, but also insulin sensitivity,
reproductive and endocrine systems, immunity, and inflammation
[3]. Numerous lines of evidence suggest that inflammation plays a
major role in the initiation and maintenance of obesity through
adipogenesis. Our present results suggest changes in cell biology
resulting from adipocyte interactions with ATMs/ASCs through
cell–to-cell contact. Cross-talk between stable adipocyte and
macrophage murine cell lines promotes proinflammatory cytokine
release [33]. Moreover, interaction between lymphocytes and
adipocytes leads to immunoregulation in the body and is
responsible for the release of adipokines such as leptin,
adiponectin, resistin, and visfatin, as well as cytokines such as
TNF-a, IL-6, and MCP-1 [3,34]. Macrophages block insulin
action in adipocytes [9], and in obese individuals macrophages
Figure 3. Differentiation of adipose stem cells to preadipocytes/adipocytes. Isolated adipocytes and ATMs/ASCs were cultured separately
for 24 hours to allow the cells to reach equilibrium and then were co-cultured for an additional 24 hours. The cells were then separated and ATMs/
ASCs were cultured for another 2 days in regular medium followed by an additional 7 days in either the same medium or adipogenic medium (A)
ATMs/ASCs without co-culture were cultured in regular medium for 2 days followed by an additional culture of 7 days in the same medium; (B) ASCs/
ATMs with co-culture were cultured in regular medium for 2 days followed by an additional culture for 7 days in regular medium. (C) Fold change in
gene expression of C/EBPa and PPARc of ASCs/ATMs with and without co-culture, cell culture conditions are the same as described above (see 3A–B);
(D) ASCs/ATMs without co-culture were cultured in regular medium for 2 days followed by an additional culture for 7 days in adipogenic medium; (E)
ASCs/ATMs with co-culture were cultured for 2 days in regular medium followed by additional culture for 7 days in adipogenic medium; (F) Fold
change in gene expression of C/EBPa and PPARc of ASCs/ATMs with and without co-culture, cell culture conditions are the same as described above
(see 3D–E).
doi:10.1371/journal.pone.0017834.g003
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resistin, an insulin resistance gene. It was recently reported that
TNF- a impairs preadipocyte differentiation through the forma-
tion of macrophage like preadipocytes [5]. Furthermore, ATMs
inhibit the differentiation of human preadipocytes through
repression of different transcriptional factors involved in adipo-
genesis [35]. Recent results indicate that ATMs could play a major
role in the production of extracellular matrix proteins that are
involved in the cellular transition of preadipocytes to adipocytes
[36]. However, the ATM regulation of adipogenesis is complex
and has yet to be elucidated. Previous studies suggest that ATMs
perform at least two roles in adipose tissue. ATMs phagocytize
debris created from rapid adipocyte proliferation, as seen in
inflammation associated with obesity. Another function of
macrophages is to produce proinflammatory cytokines that
increase adipogenesis and insulin resistance [1,37].
The present study suggests that ATMs also represent a potential
source of preadipocytes. In our nanobeads lineage tracing
experiments, a significant number of preadipocytes generated
after co-culture were found to contain an amount of fluorescent
nanobeads comparable to that localized in CD68(+) ATMs prior
to co-culture. These results suggest that the CD68(+) ATMs
contributed to the formation of new preadipocytes. CD34(+) ASCs
are currently considered to be CD14(2)/CD68(2) cells. The
Figure 4. CD14 Nanobead markers before co-culture and after co-culture. Before co-culture. (A) CD14(+) nanobeads in red were
incorporated into macrophage fraction; (C) CD14(+) indicates the presence of nanobeads in red, (D) CD68 (+) indicates the presence of ATMs in green;
(E) Coincident expression of nanobeads CD14 (+) with CD68(+) ATMs/DAPI. After co-culture: (B) CD14(+) nanobeads in red were incorporated into
preadipocytes(F) CD14(+) indicates presence of nanobeads in red (G) DLK (+) indicates presence of preadipocytes in green, (H) Coincident expression
of CD14(+) nanobeads with DLK(+) preadipocytes/DAPI.
doi:10.1371/journal.pone.0017834.g004
Figure 5. Sphere of human cells formed after 24 hours co-culture between adipocytes, and ATMs/ASPCs. (A) Sphere contains CD68 (+)/
DLK (+) cells. (B) Sphere containing CD34 (+) ASCs/S-100 (+) cells, (C) preadipocytes derived from sphere are CD68 (+)/DLK (+) (specific marker for
preadipocytes), (D) preadipocytes derived from sphere are also CD-105 (+) (marker for mesenchymal stem cells)/DLK (+).
doi:10.1371/journal.pone.0017834.g005
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insufficient to account for the large number of preadipocytes
containing nanobeads in addition to the fact that ASCs would lose
nanobeads with each mitotic division, resulting in preadipocytes
with few or no nanobeads. Therefore, our results suggest that part
of the new preadipocytes originated after co-culture are derived
from the ATMs.
Previous studies highlight a complex relationship between
lineage and phenotype for macrophages, preadipocytes, and
adipocytes. Preadipocytes have been shown to differentiate to
macrophages, dedifferentiate from adipocytes, and differentiate
back to adipocytes. Macrophages and monocytes can differentiate
to CD68 (+), S100 (+), and CD14 (2) dendritic cells, and
monocytes in some studies demonstrate characteristics of circulat-
ing stem/progenitor cells [38]. Macrophages and adipocytes both
express adipsin (complement factor D), the adipocyte differenti-
ation- dependent serine protease gene [39]. Mouse peritoneal
macrophages in co-culture with adipocytes can develop long
cellular extensions with cytoplasmic lipid vacuoles [9]. These
sources of indirect evidence would suggest that plasticity of these
cell types does not preclude macrophage to preadipocytes
differentiation.
Microarray studies comparing gene expression profiles of
macrophages and progenitor/stem cells indicate that both cell
types demonstrate the capacity for endocytosis, vesicle trafficking,
and actin remodeling [40]. In the same study, preadipocytes were
shown to demonstrate phagocytic activity. Approximately 95% of
peritoneal macrophages, 45% of mesenchymal stem cells and 35%
of preadipocytes were found to display phagocytic behavior, as
compared to only 1% of fibroblasts [40]. Phagocytic activity may
decline as differentiation proceeds towards more adipocyte-like
phenotypes. Thus, phagocytic activity may identify a preadipocyte
subset with macrophage progenitors. However, we can not discard
the possibility that CD14(+) ATMs and CD34 (+) ASCs could be
derived from a common, less differentiated cell type.
During ATMs differentiation to preadipocytes we observed cells
expressing both CD14 (+) and S-100 (+) markers. Most
preadipocytes observed were CD14 (+) to varying degrees. As
macrophages differentiated towards a preadipocyte morphology,
the cells expressed less CD14 and more DLK/S-100 (Fig. 6). As
CD14 is not expressed by mature adipocytes [41], this suggests
that preadipocytes progressively lose CD14 expression or that
CD14 cells can dedifferentiate from adipocytes with a concomitant
increase of C/EBPa and PPARc gene expression.
Our FACS data suggest that DLK (+) preadipocytes are derived
from both CD14(+) and CD14(2) precursors. Further, within the
CD14 (+) group, there exists preadipocytes that are both CD34 (+)
and CD34 (2). This would suggest a complex population of cells,
with preadipocytes deriving from multiple sources. Macrophages
and dendritic cells share the marker CD68, and adipocytes,
preadipocytes and dendritic cells are positive for S-100, but only
macrophages are CD14 (+) [42]. Similar intermediate differenti-
ation phenotypes have been demonstrated as monocytes or
macrophages differentiate to other cell types. Monocytes appear
to be able to differentiate into an endothelial precursor population
[43], and a chimeric cell that is CD68 (+), S-100 (+), and CD14 (2)
has been implicated in diseases such as scleroderma [44].
Interestingly, our co-culture studies demonstrated the formation
of CD68 (+)/DLK (+) and CD34 (+)/DLK (+) cells grouped in
spheres from which many in preadipocytes were released.
Formation of these CD68 (+)/DLK (+) and CD34 (+)/DLK (+)
cell spheres could be part of the cellular mechanisms involved in
preadipocyte proliferation during co- culture. Recently, unique
multipotent cells in adult human mesenchymal populations
(multilineage differentiating stress enduring cells, ‘‘Muse cells’’)
have been isolated from human skin fibroblasts or bone marrow
stromal cells [45]. These cells are characteristically known to form
spheres [45]. The CD68(+)/CD34(+) cell spheres originated after
co-culture (Fig. 5A, B) from which preadipocytes derived, could
also have similar pluripotent characteristics as Muse cells.
In vitro expanded, autologous preadipocytes have the potential
for future therapeutic applications, since adipocytes, ATMs and
ASCs are an abundant and easily harvested cell type. The results
of our co-culture experiments demonstrate that surgically-derived
adipose tissue can serve as a source of cells that, through co-
culture, can be used for enhanced production of preadipocytes.
Preadipocyte proliferation and differentiation does not exclusively
lead to adipogenesis. In turn, preadipocytes can be directed to
differentiate down osteogenic, chondrogenic, adipogenic, myo-
genic, cardiomyogenic, neurogenic, angiogenic, or dendritic, as
Figure 6. Morphological changes exhibited during CD14 (+) cell differentiation to preadipocytes. Expression of markers CD14
(monocytes/macrophages) (light green), S-100 (preadipocytes/adipocytes) (red), and CD34 (ASCs) (dark green), Nile Red (preadipocytes/adipocytes)
(orange). Before co-culture: (A) most of the ATMs are CD14 (+); (B–D) very few ATMs are CD14 (+)/S-100 (+); After co-culture: (E) ATMs become
enlarged in size as they transform to preadipocytes (begin to express DLK/S-100 while maintaining CD14 expression); (F) Preadipocytes are S-100 (+)
and DLK (+) and start loosing CD14 and CD34 expression; (G) As preadipocytes start differentiating to adipocytes, there is an increase cell size, lipid
accumulation (Nile Red (+) cells) and C/EBPa and PPARc gene expression. The brightness of the color inside the lowers bars indicates the changes in
cell expression markers in correlation with the morphological changes exhibited during ATMs differentiation to preadipocytes.
doi:10.1371/journal.pone.0017834.g006
Differentiation of Macrophages to Preadipocytes
PLoS ONE | www.plosone.org 7 March 2011 | Volume 6 | Issue 3 | e17834well as adipogenic, pathways. Thus, therapeutic modulation of
preadipocyte differentiation may provide new insights that may
lead to novel treatments for tissue regeneration and reconstructive
medicine.
Furthermore, understanding the regulation of the conversion of
ATMs to preadipocytes, and preadipocyte proliferation could offer
a new way to influence adipogenesis, leading to new treatments for
obesity, inflammation and type 2 diabetes.
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